drugset / Trial / NCT05222243

DPC in Primary Molars.

NCT05222243

Phase 4 Completed 60 enrolled Mansoura University
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate clinical and radiographical outcomes of direct pulp capping using calcium hydroxide (CH), mineral trioxide aggregate (MTA), and premedicated direct pulp capping (PDPC) with formocresol (FC) in primary teeth.

Timeline

Start
2019-01-01
Primary completion
2020-08-03
Completion
2020-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Calcium Hydroxide Other / unclassified
Subject Formocresol Other / unclassified
Subject Mineral Trioxide Aggregate Other / unclassified

Indications